441 related articles for article (PubMed ID: 2725104)
1. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
Torres RJ; Prior C; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
[TBL] [Abstract][Full Text] [Related]
4. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
Edwards NL; Recker D; Fox IH
J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
[TBL] [Abstract][Full Text] [Related]
5. Hypoxanthine and xanthine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase (HPRT) deficiency.
Jiménez ML; Puig JG; Mateos FA; Ramos TH; Castroviejo IP; Vázquez JO
Adv Exp Med Biol; 1989; 253A():173-9. PubMed ID: 2624187
[No Abstract] [Full Text] [Related]
6. The diagnosis of HPRT deficiency in the 21st century.
Torres RJ; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):564-9. PubMed ID: 18600505
[TBL] [Abstract][Full Text] [Related]
7. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF.
Harkness RA; McCreanor GM; Watts RW
J Inherit Metab Dis; 1988; 11(3):239-52. PubMed ID: 3148065
[TBL] [Abstract][Full Text] [Related]
8. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
[TBL] [Abstract][Full Text] [Related]
9. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
Rebentisch G; Stolz S; Muche J
Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
[TBL] [Abstract][Full Text] [Related]
10. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
Puig JG; Mateos FA; Torres RJ; Buño AS
Eur J Clin Invest; 1998 Nov; 28(11):950-7. PubMed ID: 9824441
[TBL] [Abstract][Full Text] [Related]
11. The effect of allopurinol on cerebral spinal fluid (CSF) purines in hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency syndromes.
Edwards NL; Puig JG; Mateos FA
Adv Exp Med Biol; 1986; 195 Pt A():465-9. PubMed ID: 3728180
[No Abstract] [Full Text] [Related]
12. Xanthine-containing calculi during allopurinol therapy.
Kranen S; Keough D; Gordon RB; Emmerson BT
J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
[TBL] [Abstract][Full Text] [Related]
13. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
[TBL] [Abstract][Full Text] [Related]
14. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B
Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928
[No Abstract] [Full Text] [Related]
15. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
Wu CL; Melton DW
Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
[TBL] [Abstract][Full Text] [Related]
16. Theophylline-induced increase in plasma uric acid--purine catabolism increased by theophylline.
Yamamoto T; Moriwaki Y; Suda M; Takahashi S; Hiroishi K; Higashino K
Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):257-61. PubMed ID: 1889911
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
Jacomelli G; Baldini E; Mugnaini C; Micheli V; Bernardini G; Santucci A
J Inherit Metab Dis; 2019 Jan; 42(1):178-185. PubMed ID: 30740729
[TBL] [Abstract][Full Text] [Related]
18. Adenine therapy in Lesch-Nyhan syndrome.
Bührdel P; Krüger W; Hirschberg K; Wehnert M
Acta Paediatr Hung; 1985; 26(4):327-33. PubMed ID: 4096858
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
20. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
